We are joined today by Ivan Kairatov, a biopharma expert with deep insights into the technological innovations shaping the future of medicine. We will be exploring the recent expansion of a groundbreaking protein discovery platform into Asia, discussing its installation at two leading Taiwanese
The world can fade to black not with a sudden closure of the eyes, but through a slow, imperceptible narrowing of one's peripheral vision that often goes unnoticed until it is far too late. This insidious process is the hallmark of glaucoma, a leading cause of irreversible blindness that affects
A comprehensive systematic review and meta-analysis led by researchers at the Icahn School of Medicine at Mount Sinai has established a significant association between exposure to per- and polyfluoroalkyl substances and an increased risk of gestational diabetes mellitus, alongside altered markers
In a groundbreaking study with profound implications for the fields of microbiology and astrobiology, a comprehensive taxonomic description of previously unknown cyanobacteria has been established from the extreme environments of Hawaiian steam vents. Researchers utilizing advanced genome-based
A groundbreaking discovery has unveiled a class of small molecules that effectively teach the body to eliminate its own disease-causing components, a development that could rewrite the rules for treating some of the most stubborn medical conditions. An international team of scientists has
With over two decades of research in biopharma, Ivan Kairatov has witnessed the evolution of microbiome science from a niche interest into a central player in our understanding of health. As an expert in R&D and technological innovation, he has a unique perspective on the translational gap—the
